Leading science, pioneering therapies
CRM Publications

Epigenetic remodelling licences adult cholangiocytes for organoid formation and liver regeneration.

TitleEpigenetic remodelling licences adult cholangiocytes for organoid formation and liver regeneration.
Publication TypeJournal Article
Year of Publication2019
AuthorsAloia L, McKie MAlexander, Vernaz G, Cordero-Espinoza L, Aleksieva N, van den Ameele J, Antonica F, Font-Cunill B, Raven A, Cigliano RAiese, Belenguer G, Mort RL, Brand AH, Zernicka-Goetz M, Forbes SJ, Miska EA, Huch M
JournalNat Cell Biol
Volume21
Issue11
Pagination1321-1333
Date Published2019 Nov
ISSN1476-4679
Abstract

Following severe or chronic liver injury, adult ductal cells (cholangiocytes) contribute to regeneration by restoring both hepatocytes and cholangiocytes. We recently showed that ductal cells clonally expand as self-renewing liver organoids that retain their differentiation capacity into both hepatocytes and ductal cells. However, the molecular mechanisms by which adult ductal-committed cells acquire cellular plasticity, initiate organoids and regenerate the damaged tissue remain largely unknown. Here, we describe that ductal cells undergo a transient, genome-wide, remodelling of their transcriptome and epigenome during organoid initiation and in vivo following tissue damage. TET1-mediated hydroxymethylation licences differentiated ductal cells to initiate organoids and activate the regenerative programme through the transcriptional regulation of stem-cell genes and regenerative pathways including the YAP-Hippo signalling. Our results argue in favour of the remodelling of genomic methylome/hydroxymethylome landscapes as a general mechanism by which differentiated cells exit a committed state in response to tissue damage.

DOI10.1038/s41556-019-0402-6
Alternate JournalNat. Cell Biol.
PubMed ID31685987
Grant List104151/Z/14/Z / / Wellcome Trust (Wellcome) /
092096 / / Wellcome Trust (Wellcome) /
LSMF4LIFE ECH2020-668350 / / EC | EU Framework Programme for Research and Innovation H2020 | H2020 Euratom (H2020 Euratom Research and Training Programme 2014-2018) /
C6946/A14492 / / Cancer Research UK (CRUK) /
NC/R001162/1 / / National Centre for the Replacement Refinement and Reduction of Animals in Research (NC3Rs) /
NC/R001162/1 / / National Centre for the Replacement Refinement and Reduction of Animals in Research (NC3Rs) /
MR/K50127X/1 / / RCUK | Medical Research Council (MRC) /
MR/K017047/1 / / RCUK | Medical Research Council (MRC) /
Publication institute
CRM